KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Manhattan Associates (MANH) Cash & Equivalents (2016 - 2025)

Manhattan Associates (MANH) has disclosed Cash & Equivalents for 16 consecutive years, with $328.7 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents rose 23.48% to $328.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $328.7 million through Dec 2025, up 23.48% year-over-year, with the annual reading at $328.7 million for FY2025, 23.48% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $328.7 million at Manhattan Associates, up from $263.6 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $328.7 million in Q4 2025, with the low at $11.2 million in Q1 2021.
  • Average Cash & Equivalents over 5 years is $165.9 million, with a median of $189.7 million recorded in 2022.
  • Peak annual rise in Cash & Equivalents hit 1893.74% in 2021, while the deepest fall reached 85.12% in 2021.
  • Over 5 years, Cash & Equivalents stood at $263.7 million in 2021, then decreased by 14.5% to $225.5 million in 2022, then increased by 20.08% to $270.7 million in 2023, then dropped by 1.67% to $266.2 million in 2024, then grew by 23.48% to $328.7 million in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $328.7 million, $263.6 million, and $230.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.